Double Homeobox 4-like 6: Potential Drug Target Or Biomarker (G653544)

Target Name: DUX4L6

NCBI ID: G653544

DUX4L6

Other Name(s): Double homeobox 4 like 6 | double homeobox 4 like 6 (pseudogene)

Double Homeobox 4-like 6: Potential Drug Target Or Biomarker

Double homeobox 4-like 6 (DUX4L6) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. Its function is not well understood, but it is known to be involved in the development and maintenance of tissues. DUX4L6 has also been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, it is of interest as a potential drug target or biomarker.

DUX4L6 Structure and Expression

DUX4L6 is a member of the homeobox gene family, which is characterized by the presence of a common structural motif called a double homeobox gene (DHX) in the gene name. DHX is a transmembrane protein that contains a conserved N-terminal domain, a conserved C-terminal domain, and a unique N-terminal region that includes a putative nuclear localization signal.

DUX4L6 is expressed in a variety of tissues, including the brain, heart, and gastrointestinal tract. It is highly expressed in the brain, where it is found in the cell nuclei and in the cytoplasm. DUX4L6 is also expressed in the heart, where it is found in the cardiac muscle cells and in the intercellular junctions of cardiac cells. DUX4L6 is expressed in the gastrointestinal tract, where it is found in the epithelial cells of the gut lining.

Function and Interaction

DUX4L6 is involved in the development and maintenance of tissues through its role in the Wnt signaling pathway. Wnt is a signaling pathway that is involved in the development and maintenance of tissues, including the nervous system and the gastrointestinal tract. DUX4L6 is a key component of the Wnt signaling pathway in the gastrointestinal tract, as it is involved in the development and maintenance of the gut epithelium.

DUX4L6 is also involved in the regulation of cell proliferation and cell differentiation. It has been shown to play a role in the regulation of cell proliferation in various tissues, including the brain and the heart. DUX4L6 has also been shown to play a role in the regulation of cell differentiation, as it is involved in the development of the gut epithelium.

DUX4L6 is also involved in the regulation of cell signaling pathways. It has been shown to play a role in the regulation of several signaling pathways, including the Wnt signaling pathway and theNotch signaling pathway. DUX4L6 has also been shown to interact with several other proteins, including TGF-β1, which is a key signaling molecule in the Wnt signaling pathway.

DUX4L6 and Disease

DUX4L6 is involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its involvement in these diseases makes it of interest as a potential drug target or biomarker.

DUX4L6 is involved in the development and maintenance of many tissues, including the brain, heart, and gastrointestinal tract. It is highly expressed in the brain, where it is found in the cell nuclei and in the cytoplasm. DUX4L6 is also expressed in the heart, where it is found in the cardiac muscle cells and in the intercellular junctions of cardiac cells. DUX4L6 is expressed in the gastrointestinal tract, where it is found in the epithelial cells of the gut lining.

DUX4L6 is involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its involvement in these diseases makes it of interest as a potential drug target or biomarker. For example, DUX4L6 has been shown to play a role in the development and maintenance of cancer cells. It has also been shown to play

Protein Name: Double Homeobox 4 Like 6 (pseudogene)

Functions: May be involved in transcriptional regulation

The "DUX4L6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets